Seizure

From Anvita Health Wiki

Jump to: navigation, search

Contents

More Specific Terms

Introduction

Classification

Etiology

  • pharmaceutical agents: (see drugs causing seizures)
  • central nervous system infections ( meningoencephalitis)
  • early within 1 week (usually within 24 hours)
  • late - after 3 months - usually generalized, 70% chronic
  • 18 months for glial scar to develop
  • seizures occur on impact [5]
  • toxic chemicals
  • fever
  • generally 6 months to 3 years of age
  • related to rise in temperature
  • increased incidence with infections with:
  • most often occurs following phlebotomy
  • syncopal event precedes seizure
  • idiopathic (65-70%)
  • precipitants of seizures in patients with seizure disorder

Epidemiology

  • seizures most common in patients > 60 years of age

Pathology

  • initiation
  • propagation - recruitment of normal neurons
  • clonic phase occurs after development of inhibitory circuits
  • termination

History

Clinical-manifestations

Laboratory

Diagnostic-procedures

Radiology

  • imaging modality of choice
  • all patients

Complications

  • recurrence after a single unprovoked seizure predicted by

Differential-diagnosis

  • consiousness generally not impaired
  • generally no tonic/ clonic activity
  • may have persistent focal findings
  • long duration, 10-30 minutes
  • aynchronous movement of arms & legs
  • on & off time course

Management

  • correction of underlying etiology (first line)
  • pharmacologic
  • depends upon type of seizure & patient's ability to tolerate side effects
  • indications for therapy
  • patient with single, unprovoked, generalized tonic-clonic seizure may not require therapy
  • 20% recurrence rate in next 5 years if neurologic examination, EEG & MRI are normal
  • it is reasonable NOT to start therapy for an initial single seizure, especially if a preventable precipitating event can be identified
  • early therapy has no effect on long-term prognosis [9]
  • important for patients with:
  • indadequate seizure control
  • signs or symptoms of toxicity
  • appropriate dose is dose that controls seizures in the absence of adverse effects, regardless of serum levels
  • without seizures for 2 years with normal EEG
  • known precipitant of seizures without underlying brain disease
  • anticonvulsive therapy should be tapered, not abruptly discontinued
  • relapse after stopping anticonvulsants in adults is 25-60% over 2 years [5]
  • 30-40% of patients do not respond to anticonvulsants [5]
  • see specific seizure type for specific agents
  • referral for patients not controlled by medication
  • failure to control seizures despite adequate trials of 2 appropriate anticonvulsants [5]
  • treatment option for medically refractory seizures in patients not candidates for traditional surgery
  • seizure-free for 6 to 12 months before a patient with seizure disorder can legally drive (Calif); differs in different states [6]
  • patient education:
  • avoid swimming, heights, driving, operating heavy equipment
  • keep seizure diary for return visits to physician
  • Follow-up:
  • every 3-6 months to evaluate seizure control

More General Terms

Additional Terms

References

  1. Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 829-39
  2. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 1034-35
  3. Alan Gelb, UCSF, Department of Emergency Services, San Francisco General Hospital, 1998
  4. Chan & Winkle, Diagnostic History & Physical Examination, Current Clinical Strategies Publishing. Laguna Hills, 1996
  5. Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15 American College of Physicians, Philadelphia 1998, 2006, 2009
  6. Journal Watch 22(1):8, 2002 [1]
  7. Prescriber's Letter 10(1):4 2003
  8. Journal Watch 24(10):79-80, 2004 Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet. 2004 Apr 10;363(9416):1184-6. PMID: [2]
  9. Journal Watch 25(15):117, 2005 Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D; Medical Research Council MESS Study Group. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet. 2005 Jun 28;365(9476):2007-13. PMID: [3]
  10. Thijs RD et al. Transient loss of consciousness through the eyes of a witness. Neurology 2008 Nov 18; 71:1713. PMID: [4]
  11. NIH Institute & Center Resources [5]
  12. National Guideline Clearinghouse
    - Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. ngc-guideline: [6]
    - Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology ngc-guideline: [7]
    - Use of serum prolactin in diagnosing epileptic seizures. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. ngc-guideline: [8]
    - Seizures-child. (American College of Radiology) ngc-guideline: [9]
    - Care of the patient with seizures. 2nd edition. American Association of Neuroscience Nurses ngc-guideline: [10]

Personal tools